Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats

Stroke

Volumn 45, Issue 10, 2014, Pages 3048-3054

  Liang, Xiping ^a,b   Hu, Qin ^a   Li, Bo ^a   McBride, Devin ^a   Bian, Hetao ^a   Spagnoli, Pierre ^a   Chen, Di ^a   Tang, Jiping ^a   Zhang, John H ^a  

^a LOMA LINDA UNIVERSITY   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; follistatin related proteins; infarction; middle cerebral artery

Indexed keywords

CASPASE 3; DISCO INTERACTING PROTEIN 2 HOMOLOG A; DNA NUCLEOTIDYLEXOTRANSFERASE; FOLLISTATIN; FOLLISTATIN LIKE 1; PROTEIN; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; FOLLISTATIN RELATED PROTEIN; FSTL1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; ISCHEMIC HEART DISEASE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TUNEL ASSAY; WESTERN BLOTTING; ANIMAL; CELL SURVIVAL; CEREBRAL ARTERY DISEASE; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; METABOLISM; NERVE CELL; PHYSIOLOGY; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; FLUORESCENT ANTIBODY TECHNIQUE; FOLLISTATIN-RELATED PROTEINS; GENE KNOCKDOWN TECHNIQUES; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84922479883     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006092     Document Type: Article

References (20)

1. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al; INTERSTROKE investigators. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. Lancet. 2010;376:112-123.
2. Brainin M, Teuschl Y, Kalra L. Acute treatment and long-term management of stroke in developing countries. Lancet Neurol. 2007;6:553-561.
3. Broughton BR, Reutens DC, Sobey CG. Apoptotic mechanisms after cerebral ischemia. Stroke. 2009;40:e331-e339.
4. Ogura Y, Ouchi N, Ohashi K, Shibata R, Kataoka Y, Kambara T, et al. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models. Circulation. 2012;126:1728-1738.
5. Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, Izumiya Y, et al. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem. 2008;283:32802-32811.
6. Oshima Y, Ouchi N, Sato K, Izumiya Y, Pimentel DR, Walsh K. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation. 2008;117:3099-3108.
7. El-Armouche A, Ouchi N, Tanaka K, Doros G, Wittköpper K, Schulze T, et al. Follistatin-like 1 in chronic systolic heart failure: A marker of left ventricular remodeling. Circ Heart Fail. 2011;4:621-627.
8. Ouchi N, Asaumi Y, Ohashi K, Higuchi A, Sono-Romanelli S, Oshima Y, et al. DIP2A functions as a FSTL1 receptor. J Biol Chem. 2010;285:7127-7134.
9. Hu Q, Ma Q, Zhan Y, He Z, Tang J, Zhou C, et al. Isoflurane enhanced hemorrhagic transformation by impairing antioxidant enzymes in hyperglycemic rats with middle cerebral artery occlusion. Stroke. 2011;42:1750-1756.
10. Ma Q, Chen S, Hu Q, Feng H, Zhang JH, Tang J. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann Neurol. 2014;75:209-219.
11. Hu Q, Chen C, Yan J, Yang X, Shi X, Zhao J, et al. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusioninduced focal ischemia rat model. Exp Neurol. 2009;216:35-46.
12. Kristian T, Balan I, Schuh R, Onken M. Mitochondrial dysfunction and nicotinamide dinucleotide catabolism as mechanisms of cell death and promising targets for neuroprotection. J Neurosci Res. 2011;89:1946-1955.
13. Sylva M, Moorman AF, van den Hoff MJ. Follistatin-like 1 in vertebrate development. Birth Defects Res C Embryo Today. 2013;99:61-69.
14. Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC, Cheung AN. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: A differential expression and functional analysis. Carcinogenesis. 2009;30:114-121.
15. Clutter SD, Wilson DC, Marinov AD, Hirsch R. Follistatin-like protein 1 promotes arthritis by up-regulating IFN-gamma. J Immunol. 2009;182:234-239.
16. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108-2118.
17. Schiekofer S, Shiojima I, Sato K, Galasso G, Oshima Y, Walsh K. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics. 2006;27:156-170.
18. Lara-Pezzi E, Felkin LE, Birks EJ, Sarathchandra P, Panse KD, George R, et al. Expression of follistatin-related genes is altered in heart failure. Endocrinology. 2008;149:5822-5827.
19. Widera C, Horn-Wichmann R, Kempf T, Bethmann K, Fiedler B, Sharma S, et al. Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay. Clin Chem. 2009;55: 1794-1800.
20. Tanaka M, Murakami K, Ozaki S, Imura Y, Tong XP, Watanabe T, et al. DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1-analysis of their binding with TGF-? superfamily proteins. FEBS J. 2010;277:4278-4289.